Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.46 |
| ▸ | CES1 | P23141 | 5/20 | 0.46 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8384510 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8749109 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8054701 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8384626 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL4431228 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL10426860 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8048379 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8384533 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8384429 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL8051829 | 1.00 | FAAH (0.46) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10092599-B2 | Methods for enhancing hematopoietic stem/progenitor cell engraftment | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2018-10-09 | — | — | US | claimed |
| US-20150246075-A1 | METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT | CHILDREN'S MEDICAL CENTER CORPORATION | 2015-09-03 | — | — | US | claimed |
| US-20140212949-A1 | METHOD FOR PREPARING MICROVESICULAR ADAM15 | INDUSTRY ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2014-07-31 | — | — | US | claimed |
| US-20130203715-A1 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | PULMATRIX, INC. (US) | 2013-08-08 | — | — | US | claimed |
| WO-2010096264-A2 | METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2010-08-26 | — | — | WO | claimed |
| EP-0995430-A2 | Use of diacylolycerols for enhancing the barrier function of the skin | Beiersdorf Aktiengesellschaft (DE) | 2000-04-26 | — | — | EP | claimed |
| EP-0655907-B1 | USE OF DIACYLOLYCEROLS FOR INCREASING THE MELANIN CONTENT IN MELANOCYTES | UNIV BOSTON (US) | 1999-04-28 | — | — | EP | claimed |
| US-5700450-A | Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1997-12-23 | — | — | US | claimed |
| EP-0706369-B1 | STIMULATION OF TANNING BY DNA FRAGMENTS | UNIV BOSTON (US) | 1997-12-17 | — | — | EP | claimed |
| EP-0706369-A1 | STIMULATION OF TANNING BY DNA FRAGMENTS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1996009810-A1 | METHODS FOR ENHANCING MELANIN SYNTHESIS IN MELANOCYTES USING DIACYLGLYCEROLS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-04-04 | — | — | WO | claimed |
| WO-1995001773-A9 | STIMULATION OF TANNING BY DNA FRAGMENTS | — | 1995-02-16 | — | — | WO | claimed |
| WO-1995001773-A1 | STIMULATION OF TANNING BY DNA FRAGMENTS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1995-01-19 | — | — | WO | claimed |
| EP-0334585-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1989-09-27 | — | — | EP | claimed |
| US-20240156728-A1 | MONOVALENT METAL CATION DRY POWDERS FOR INHALATION | PULMATRIX OPERATING CO INC (US) | 2024-05-16 | — | — | US | disclosed |
| US-20240150719-A1 | MAGNETIC SHEAR BIOREACTOR APPARATUS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-05-09 | — | — | US | disclosed |
| EP-4294919-A1 | MAGNETIC SHEAR BIOREACTOR APPARATUS AND METHODS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-0334586-A1 | Carbohydrate lactam derivatives and their use in cosmetic compositions | UNILEVER PLC (GB) | 1989-09-27 | — | — | EP | disclosed |
| US-4855287-A | ANTIBIOTICS | KOWA COMPANY, LTD. (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0295092-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130203715-A1 | USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS | TRPV1, TRPC4, TRPC3 | FAAH 168/4885CES1 2999/4885CES2 2716/4885 |
| US-20150246075-A1 | METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT | HCLS1, MCL1, THPO | FAAH 3539/4885CES1 2271/4885CES2 1926/4885 |
| US-10092599-B2 | Methods for enhancing hematopoietic stem/progenitor cell engraftment | HCLS1, MCL1, THPO | FAAH 3539/4885CES1 2271/4885CES2 1926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.